Pearl Pathways’ own COO and Co-Founder, Gretchen Bowker will be holding a webinar on FDA regulatory requirements for the manufacturing and commercialization of dietary supplements via ComplianceOnline. A few of the topics include a review of FDA regulations in the...
Fred Upton, chairman of the House Energy and Commerce Committee, and Rep. Diana DeGette have recently launched the 21st Century Cures initiative, a bill intended to improve clinical trials and expedite the drug and device approval process. Upton and Degette plan to...
Pearl Pathways is proud of employee Heidi Strunk, as she earned a publication in the RAPS online journal Regulatory Focus. The article is located on RAPS.org (Login and Password required) and is entitled “Types of In Vitro Diagnostics: Clearing Up the Confusion.” By...
Diversity Alliance for Science (DA4S) is a non-profit organization focused on supporting, developing, and connecting with a diverse group of suppliers in the Life Science, Pharmaceutical, Bio-Tech, and Healthcare industries. Our President and CEO is attending the DA4S...
Pearl IRB is proud to announce its recent accreditation with the Association for the Accreditation of Human Research Protection Programs (AAHRPP). Pearl IRB earned this distinction by demonstrating two primary techniques including extensive safeguards in all levels of...
As a sponsor of the 2014-2015 Indiana Life Sciences Collaboration Conference Series, Pearl Pathways would like to announce the upcoming conference entitled Mobile Healthcare: Where Does New IT Intersect with Healthcare? We invite you to join us at the event on Friday,...